What We Do
Medical Supply Chain frees Healthcare markets from exorbitant single sources middlemen with intelligent automated procurement networks. Utilizing new AI-driven interfaces, health system managers can now factually verify in real time that their institution is getting the most competitive priced supplies from any distributor on any product to meet President Elect Donald Trump’s healthcare advisory team’s future standards to be set by the Department of Government Efficiency to be led by Elon Musk, owner of Tesla and X; Vivek Ramaswamy, founder of Roivant Sciences; and Brad Smith, founder and CEO of the healthcare investment firm Russell Street Ventures. Now medical supply procurement managers will be able to easily meet the increased efficiency targets that will be set for all hospitals receiving Medicare or government subsidized insurance reimbursements in the post “Healthcare Middlemen” and Group Purchasing Organization “single source contract” era.
Medical Supply Chain has revolutionized healthcare procurement for global healthcare markets by sourcing multiple medical equipment and supplies manufacturers for every need.Thanks to AI-driven tech and a super user-friendly platform, we make it a breeze for healthcare markets to connect directly with manufacturers from all over the world, including U.S. manufacturers. Imagine searching for medical products and having several manufacturers pop up on your screen like magic!
Behind the user-friendly interface, Medical Supply Chain is the first intelligent automated sourcing platform that creates new specific networks in real time to optimize the fulfillment of each request to the sole advantage of the individual health system making the request. Medical Supply Chain now utilizes Artificial Intelligence in combination with simultaneous real time data from worldwide producers of FDA approved materials, manufacturers of subcomponents, devices and instruments, along with thousands of separate consumables used each day by every hospital worldwide to coordinate the production, shipment, importation, and quality conformance acceptance of each health system request.
To learn more Contact Us
Our Mission
Prior to Covid-19 healthcare markets and providers were unaware how fragile their supply chain’s are or how family, friends or patients are negatively affected when life saving medical equipment and supplies are not accessible.
To solve this problem MSC has developed an open-source open-enrollment supply chain platform that integrates, aggregates and consolidates medical products with healthcare systems worldwide.
The benefit of this development provides healthcare markets and providers with a “neutral utility” alternative to the antiquated mark up and discount schemes used by resellers and distributors which compound many of the healthcare supply chain problems today.
Our solutions are simple, healthcare markets and providers now have a choice between the antiquated mark up and discount schemes and a more efficient direct procurement model with global manufacturers that guarantee direct access to medical equipment and supply manufacturers when you need them most.
To learn more Contact Us
From The Beginning
Mr. Lipari’s career began when family businesses required group purchasing organizations in the mid 1980’s to serve mass-merchandisers, automotive wholesalers and grocery distributors.
That is when Mr. Lipari mastered an appreciation for integrated supply chain technologies before turning that experience to healthcare in the 1990’s; consulting and implementing supply chain technologies with Wellmark a subsidiary of Joseph Kasputys company Primark, one of the first healthcare information systems (HIS) utilizing electronic billing.
Following Mr. Lipari’s contributions with Wellmark he founded Physicians Management Group where he designed, developed, and implemented his Material Management Information Systems (MMIS) for non-acute healthcare markets. Mr. Lipari then integrated his MMIS system on-line as the first material management supply chain platform, which was adopted but misused by several GPO’s to monopolize medical product contracting rebate and kickback schemes.
The GPO monopolization schemes were then investigated during Senate hearings from 2002 – 2006 by the U.S. Senate Judiciary Sub Committee on Anti-Trust in “Hospital Group Purchasing: Lowering Costs at the Expense of Patient Health and Medical Innovations.”
As a result of Lipari exposing GPO monopolization practices to artificially inflate hospital product costs, the US Senate Judiciary Committee amended the False Claims Act (the “FCA”) when Congress passed the Fraud Enforcement and Recovery Act (“FERA”), and passed the Patient Protection and Affordable Care Act (“PPACA) that changed to the FCA in the health care sector so that indirect federal fund recipients including hospital supply GPOs and distributors would be liable for the artificial hospital supply cost inflation fraud detailed in Lipari’s company testimony and litigation.
To learn more Contact Us